Sort
39,280 grants matching “leukemia”
Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response
$377,999Mercedes R. Rincon · University Of Colorado Denver · R01 · FY2022 · CA
Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response
$377,999Mercedes R. Rincon · University Of Colorado Denver · R01 · FY2025 · CA
HUMORAL REGULATION OF NORMAL AND MALIGNANT HEMATOPOIESIS
$377,995Sloan-Kettering Institute For Cancer Res · R01 · FY2002 · CA
Role of TET2 in normal hematopoiesis and pathogenesis of myeloid malignancies
$377,993Mingjiang Xu · University Of Miami School Of Medicine · R01 · FY2015 · HL
The Role of Zinc Finger Genes in Leukemogenesis
$377,941Sinisa Dovat · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2012 · HL
Mechanism(s) of TAL1- and NOTCH1-mediated Leukemogenesis
$377,922Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · CA
ARID5B and disparities of childhood leukemia
$377,891Jun J. Yang · St. Jude Children'S Research Hospital · U01 · FY2015 · CA
Hoxa9, Meis1, and Pbx in Self-renewal and Leukemogenesis
$377,871Mark P Kamps · University Of California, San Diego · R01 · FY2010 · CA
Support for Infrastructure of Childhood Leukemia Environmental Research
$377,828Catherine Metayer · University Of California Berkeley · R24 · FY2019 · ES
Mechanisms of Resistance to Gemtuzumab Ozogamicin
$377,778Fred Hutchinson Cancer Research Center · R01 · FY2003 · CA
Molecular Events Initiating B Cell Fate Determination
$377,750Kay Lynn Medina · Mayo Clinic Rochester · R01 · FY2011 · HL
Molecular Events Initiating B Cell Fate Determination
$377,750Kay Lynn Medina · Mayo Clinic Rochester · R01 · FY2009 · HL
Molecular Events Initiating B Cell Fate Determination
$377,750Kay Lynn Medina · Mayo Clinic Rochester · R01 · FY2010 · HL
Molecular Events Initiating B Cell Fate Determination
$377,750Kay Lynn Medina · Mayo Clinic Rochester · R01 · FY2012 · HL
Regulation of Chromatin Structure Dynamics in Hematopoietic and Leukemic Stem Cel
$377,719Camilla Forsberg · University Of California Santa Cruz · R01 · FY2013 · HL
THYMOMA TYROSINE PROTEIN KINASE
$377,679Salk Institute For Biological Studies · R01 · FY2002 · CA
ROLE OF SHARP AND ITS ISOFORMS IN HEMATOPOIESIS
$377,677Diane A Hall · Yale University · P01 · FY2007 · HL
Targeting DNA repair to eradicate TKi-refractory/resistant CML and Ph+ALL
$377,631Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2024 · CA
Emulsion digital PCR for TKI discontinuation studies
$377,611Daniel T Chiu · University Of Washington · R01 · FY2018 · EB
IGF/IGF1R signaling in hematopoiesis and leukemogenesis
$377,588Zhe Li · Brigham And Women'S Hospital · R01 · FY2011 · HL
Phase 2 Study of Abatacept with Calcineurin Inhibition and Methotrexate for GVHD
$377,580Leslie S Kean · Seattle Children'S Hospital · R01 · FY2013 · FD
Development and Mechanistic Studies of an Engineered Human Enzyme to Abrogate Immune Suppression due to Elevated Methylthioadenosine (MTA) by MTAP null/low Tumors
$377,573Everett Stone · University Of Texas At Austin · R01 · FY2020 · CA
The Role of Pericytes in the Vascular Dysfunction of Sepsis
$377,539Hongkuan Fan · Medical University Of South Carolina · R35 · FY2025 · GM
The Role of Pericytes in the Vascular Dysfunction of Sepsis
$377,539Hongkuan Fan · Medical University Of South Carolina · R35 · FY2023 · GM
The Role of Pericytes in the Vascular Dysfunction of Sepsis
$377,539Hongkuan Fan · Medical University Of South Carolina · R35 · FY2024 · GM